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Most (> 70%) of the body lead burden in chil-
dren is contained within the skeleton (Barry
1981). Because lead is qualitatively a biologic
analog to calcium, its uptake and release from
the skeleton are partly controlled by processes
affecting bone growth and turnover (Hu et al.
1998; O’Flaherty 1998). In adults, skeletal
lead is contained within long-lived compart-
ments of cortical [elimination half-life (t1/2) >
5–10 years] and trabecular (elimination t1/2 >
1 year) bone, with comparatively small
amounts of lead in tissue compartments that
rapidly exchange with extracellular ﬂuid and
plasma (Hu et al. 1998; Leggett 1993;
O’Flaherty 1998; Rabinowitz et al. 1976). In
children, however, the turnover rates of skele-
tal reservoirs of lead and the impact of bone
lead releases on blood lead content are not well
understood. In children exposed to lead haz-
ards, the accumulation of lead in bone and
other tissues is of serious concern because these
body lead stores are believed to serve as inter-
nal sources of lead to blood during bone
remodeling (Gulson et al. 1996, 1997b;
Leggett 1993; Nordberg et al. 1991;
O’Flaherty 1994). Moreover, mobilization of
accumulated skeletal lead stores back into
blood is suspected to be responsible for the
apparent limited success of various lead hazard
control measures to decrease blood lead levels
in exposed children (Burgoon et al. 1995; Rust
et al. 1999). These abatement efforts typically
result in reductions of blood lead levels in
exposed children of no more than 30% when
evaluated within several months after interven-
tion [U.S. Environmental Protection Agency
(EPA) 1995].
The importance of bone lead storage and
mobilization in controlling blood lead levels
has been documented in adults (Rabinowitz
et al. 1976; Smith et al. 1996). Increased bone
resorption in winter months (Oliveira et al.
2002), during pregnancy and lactation
(Gulson et al. 1997a; Lagerkvist et al. 1996;
Manton et al. 2003; Rothenberg et al. 2001;
Silbergeld 1991; Tellez-Rojo et al. 2002),
under hyperthyroidism conditions (Goldman
et al. 1994), or due to skeletal disease (Berlin
et al. 1995) has been associated with elevated
blood lead levels. In addition, experimental
lead isotope studies in nonhuman primates
have demonstrated lead releases from bone to
blood (Inskip et al. 1996). The existence of a
relationship between bone remodeling and
blood lead content has been also hypothesized
for children (Angle et al. 1995; Gulson et al.
1996; Gwiazda and Smith 2000; Hu et al.
1998; Manton et al. 2000; O’Flaherty 1994;
Rust et al. 1999), though this link is difﬁcult
to document partly because of the challenges
of determining bone lead burdens in pediatric
populations (Hu et al. 1998).
Measurements of bone lead content in
children could be used to establish empirical
relationships between bone and blood lead
levels in pediatric populations. However, this
relationship would be affected by other fac-
tors such as current lead intake, age, and his-
tory of exposure that are thought to affect the
nature of the bone lead–blood lead relation-
ship. Nevertheless, because of the importance
of bone lead in human lead toxicokinetics,
the potential effect of bone turnover on blood
lead content has been included in the struc-
ture of pharmacokinetic models of childhood
lead poisoning. These include the Integrated
Exposure and Uptake Biokinetic model
(White et al. 1998), O’Flaherty’s (1998)
physiologically based pharmacokinetic model,
and Leggett’s (1993) biokinetic lead model.
Validation of these models for bone lead
release has been limited, however, because of
the scarcity of suitable pediatric data for accu-
rate ground-truthing and calibration.
Lead isotopic methods provide an alterna-
tive approach to estimate the impact of endo-
genous sources of lead on blood lead content
(Gulson et al. 1997b; Smith et al. 1996). In its
simplest form, this approach apportions the
blood lead isotopic composition as a mixture
of two end members: the lead isotopic compo-
sition of intake and the lead isotopic composi-
tion of the endogenous source(s). The critical
challenge in applying this approach is the
characterization of the isotopic composition of
the end members contributing lead to blood
(e.g., external sources and the skeleton). To
this end, a variety of experimental designs
have been used in adults. In these designs, the
isotopic composition of the lead intake either
was estimated from analysis of environmental
samples (Gulson et al. 1995, 1996; Manton
1985; Smith et al. 1996) and from duplicate
diets (Gulson et al. 1997a; Manton 1985;
Rabinowitz et al. 1976) or was purposefully
changed (Facchetti 1989; Rabinowitz et al.
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Lead hazard control measures to reduce children’s exposure to household lead sources often result
in only limited reductions in blood lead levels. This may be due to incomplete remediation of lead
sources and/or to the remobilization of lead stores from bone, which may act as an endogenous
lead source that buffers reductions in blood lead levels. Here we present a noninvasive isotopic
approach to estimate the magnitude of the bone lead contribution to blood in children following
household lead remediation. In this approach, lead isotopic ratios of a child’s blood and 5-day
fecal samples are determined before and after a household intervention aimed at reducing the
child’s lead intake. The bone lead contribution to blood is estimated from a system of mass bal-
ance equations of lead concentrations and isotopic compositions in blood at the different times of
sample collection. The utility of this method is illustrated with three cases of children with blood
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general, the lead isotopic compositions of feces matched or were within the range of the lead iso-
topic compositions of the household dusts with lead loadings exceeding U.S. Environmental
Protection Agency action levels. This isotopic agreement underscores the utility of lead isotopic
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1973, 1976, 1977). The lead isotopic composi-
tion of the endogenous skeletal source was esti-
mated on the basis of the assumed historical
exposure (Gulson et al. 1995, 1997b) or meas-
ured directly on bone samples (Manton 1985;
Smith et al. 1996). In some cases the fraction
of lead derived from the skeleton was calcu-
lated from simple proportionality (Gulson
et al. 1995; Smith et al. 1996), whereas in oth-
ers its computation required the use of mathe-
matical models (Colombo and Fantechi 1983;
Rabinowitz et al. 1973, 1976, 1977).
Studies by Gulson et al. (1996, 1997b),
who used the lead isotopic approach to esti-
mate the skeletal lead contribution to blood in
children, took advantage of the fact that the
studied children had lived at a younger age in
locations with a presumably well-characterized
environmental lead isotopic composition,
which was different from that of their current
exposure. The authors then assumed that the
skeletal lead carried a homogeneous isotopic
signature from the earlier exposure. Although
their work provides supporting evidence for
the contribution of bone lead to blood lead in
children, their methodologic approach is lim-
ited to the special circumstances of a child
moving to a very different location. In most
cases, however, the lead isotopic composition
of children’s skeletal tissue cannot be empiri-
cally ascertained, and therefore the apportion-
ment of the blood lead isotopic composition
between the skeletal and the exogenous end
members is not possible. Isotopic measure-
ments of shed deciduous lead in teeth could
serve as proxy of the lead isotopic composition
of bone, but this opportunistic sampling
would be useful only for children ≥ 5 years of
age. Similarly, it is often difﬁcult to obtain a
weighted average lead isotopic composition of
lead intake, given the various possible sources
and pathways of exposure (dust, soil, food, air)
from which children absorb lead. Isotopic
characterization of lead intake has been done
from duplicate diets. However, this sampling
method does not include all sources of lead
exposure to the child, especially for younger
children who may ingest high amounts of lead
from environmental sources through increased
hand-to-mouth activity.
Here we present a noninvasive isotopic
approach to estimate the magnitude of the
bone lead contribution to blood in children
following household lead remediation. This
approach does not require lead isotopic meas-
urements of bone, nor does it assume the lead
isotopic ratio of bone on the basis of the child’s
lead exposure history. Instead, blood and feces
are sampled for lead concentration and isotopic
analyses before and after implementation of
environmental lead hazard control measures to
reduce the child’s lead exposure(s). Estimation
of the bone lead contribution to blood using
this method is illustrated with three cases of
childhood lead poisoning. In addition, the
sources of lead exposure to the child are identi-
fied from a comparison of the lead isotopic
compositions of household sources and feces,
using the latter as a surrogate measure of the
magnitude and isotopic composition of lead
intake.
Materials and Methods
Experimental approach. The isotopic compo-
sition of blood is a function of the isotopic
compositions and relative lead contributions
of exogenous intake and endogenous sources.
Here, we assume that the isotopic composi-
tion of feces reﬂects the isotopic composition
of lead intake. However, the isotopic compo-
sition of bone is not known. To calculate this
value and be able to solve the relative lead
contributions from intake and from the skele-
ton to blood, we rely on an induced change in
the magnitude and isotopic composition of
lead intake through the elimination of identi-
ﬁed household sources of lead exposure (i.e.,
household lead abatement intervention). The
assumption in this approach is that by reduc-
ing the magnitude of the child’s lead intake,
the relative contribution of lead to blood
from the endogenous skeletal source increases
and the lead isotopic composition of blood
shifts toward the isotopic value of bone.
We applied a system of linear equations to
calculate the endogenous lead contribution to
blood, with lead content and isotopic compo-
sition of blood and feces before and after
intervention as independent variables. More
generally, this system of equations can be
applied between any two time points with
different blood lead levels, regardless of the
cause and direction of change in blood lead
content (increase or decrease).
We used the following mass balance equa-
tions for lead content and for lead isotopes at
two different time points, t1 and t2, to describe
the mixing of lead in blood:
Pbblood
t1 = Pbin
t1 + Pbbone
t1 [1]
Pbblood
t2 = Pbin
t2 + Pbbone
t2 [2]
(207Pb/206Pb)blood
t1 × Pbblood
t1
= (207Pb/206Pb)in
t1 × Pbin
t1
+ (207Pb/206Pb)bone
t1 × Pbbone
t1 [3]
(207Pb/206Pb)blood
t2 × Pbblood
t2
= (207Pb/206Pb)in
t2 × Pbin
t2
+ (207Pb/206Pb)bone
t2 × Pbbone
t2, [4]
where Pbblood is the concentration of lead in
blood, in micrograms per deciliter. Pbin and
Pbbone are the amounts of lead in blood from
external intake and from bone, respectively,
in micrograms per deciliter. (207Pb/206Pb)in is
the isotopic ratio of lead in blood derived
from external intake, and it is assumed to be
identical to the isotopic composition of lead
measured in feces, as follows:
(207Pb/206Pb)in
t1 = (207Pb/206Pb)feces
t1
(207Pb/206Pb)in
t2 = (207Pb/206Pb)feces
t2.
It is also assumed that the lead isotopic
composition of bone did not change between
the two time points considered, as follows:
(207Pb/206Pb)bone
t1
= (207Pb/206Pb)bone
t2
= (207Pb/206Pb)bone.
It is assumed that the amount of lead in
blood from the external intake, Pbin, is propor-
tional to the rate of lead intake. Here, the rate
of lead excretion (Pbfeces, in micrograms lead
per day) is used as a surrogate of the rate of
lead intake, as follows:
Pbin
t1 = K × Pbfeces
t1 [5]
Pbin
t2 = K × Pbfeces
t2, [6]
where K is a biokinetic constant (in micrograms
per deciliter/micrograms excreted per day) that
relates the lead content of feces to the amount
of lead in blood from external intake. This bio-
kinetic constant K is different from the more
familiar term biokinetic slope factor (BKSF),
which refers to the increase in blood lead per
unit of lead absorbed (instead of excreted)
across the gastrointestinal (GI) tract (Bowers
et al. 1994; Bowers and Cohen 1998; U.S. EPA
2003). This approach yields a solvable system
of six equations with six unknowns, K, Pbin
t1,
Pbin
t2, Pbbone
t1, Pbbone
t2, (207Pb/206Pb)bone, with
no need for parameterization (e.g., use of inde-
pendently obtained parameters that describe
fractional lead absorption across the GI tract,
rate of bone turnover, etc.).
Notably, this method can be applied to
obtain the relative contributions of lead from
the intake and the skeleton to blood only when
the lead isotopic compositions of the external
(intake) and internal (skeleton) sources are dif-
ferent. In practical terms, because the isotopic
composition of the skeletal lead source typi-
cally cannot be known, this approach can be
applied only if the difference between the
blood and intake lead isotopic compositions is
greater than the isotopic measurement error.
Subjects. Children were recruited by the
Children’s Hospital of Philadelphia from refer-
rals by the Philadelphia Childhood Lead
Poisoning Prevention Program. Inclusion crite-
ria were that blood lead level was between 15
and 35 µg/dL, the child was < 6 years of age,
the child spent most of his or her waking time
within a single household environment, and
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were measurably different (to conﬁrm the latter
criterion, blood and fecal samples were ana-
lyzed within 2 weeks following recruitment).
Four cases were recruited. Three boys, 14, 20,
and 46 months of age, met the inclusion crite-
ria and were retained in the study (Table 1).
One case did not meet the latter criterion
above and was excluded from follow-up.
Informed written consent was obtained from
all parents/guardians. All procedures used in
the recruitment of subjects, including the
administered questionnaire and the collection
of biologic and environmental samples,
received prior review and approval by the
human subjects institutional review boards of
the University of California at Santa Cruz and
the Children’s Hospital in Philadelphia.
Sample collection. Blood, 5-day complete
fecal samples, and household environmental
samples were collected at enrollment. Within
2 months, a state-certified lead abatement
contractor conducted a thorough cleaning of
the household environment, including high-
efﬁciency particulate air (HEPA) vacuuming
and wet washing of all horizontal surfaces
with trisodium phosphate detergent. Blood
and 5-day fecal samples were collected a sec-
ond time (t2) at least 1 month after the house-
hold cleaning. Finally, a third round of blood
and 5-day fecal collections was performed at
least 3 months after the second round of sam-
ple collection (Table 1).
Blood samples (3 mL) were collected into
low-lead heparinized Vacutainer tubes (no.
367734; Becton-Dickinson, Franking Lakes,
NJ) by the Children’s Hospital of Philadelphia.
Parents collected daily fecal samples in diapers
provided by the study (LUVS Ultra Leak
Guards no. 4; Procter & Gamble, Cincinnati,
OH) or in perforated urine collection “hats”
(McKesson Medical Surgical, Richmond, VA)
that had been prewashed with distilled water
and air-dried in a filtered-air environment.
Household samples of all deteriorated paints,
floor dusts, and soils, if appropriate, were
sampled by the Philadelphia Health Depart-
ment following U.S. Department of Housing
and Urban Development (HUD) guidelines
(HUD 1995). All samples were shipped to
the University of California at Santa Cruz for
lead concentration and isotopic composition
analyses, as described below.
Analytical techniques. Processing of bio-
logic samples was conducted under trace-
metal–clean HEPA-filtered air (Class-100)
conditions using clean techniques (Smith et al.
1992). Acids used in sample processing and
analyses were quartz double distilled, water
was ultrapure grade (18 MΩ.cm), and all
sample-processing plasticware was acid cleaned
(Flegal and Smith 1992).
Blood samples were processed in triplicate
as described in Gwiazda and Smith (2000).
Ultrapure water was added to fecal samples
(at least two parts water to one part feces,
wt/wt), and the mix was homogenized with a
stainless steel blender. Duplicate aliquots
(~2.5 g each) of the fecal homogenate were
dried and digested overnight in 2–3 mL sub-
boiling 16N HNO3. After evaporation to
dryness, samples were reconstituted in 1N
HNO3, and centrifuged at 15,000 × g. The
supernatant was spiked with 209Bi for analysis
in an inductively coupled plasma mass spec-
trometer (ICP-MS), as described below.
Paint (0.1–0.2 g) and soil (~1 g) samples
were homogenized with mortar and pestle,
weighed, and digested in trace-metal–grade
16N HNO3 for at least 12 hr. After evapora-
tion to dryness, samples were reconstituted in
1N HNO3, filtered (Whatman filter paper
no. 4; Fisher Scientiﬁc, Pittsburgh, PA), and
spiked with 209Bi for analysis by ICP-MS.
Dust wipes were digested in a similar fashion.
A double focusing magnetic sector ICP-
MS (Finnigan Element, Thermo Electron
Corporation, Bremen, Germany) was used for
lead isotopic and concentration measurements
using the method of Gwiazda et al. (1998),
but with shorter scan times of 10 msec for
each mass. 204Pb abundance was not meas-
ured. National Institute of Standards and
Technology (NIST) standard reference mater-
ial (SRM) 955b level 4 (lead in blood) was
used to evaluate the precision of lead isotopic
and accuracy of lead concentration measure-
ments in blood. The measured lead concen-
tration of the 955b blood SRM was 38.6 ±
1.3 µg/dL (2× SE, n = 5), in good agreement
with the certified value of 39.4 µg/dL. The
precision of the blood 207Pb/206Pb ratio meas-
urements over the course of the study was
0.2% [2× relative standard deviation (RSD)],
based on the analyses of NIST 955b blood
SRM over 5 different days of analyses. The
precision of blood 207Pb/206Pb and 208Pb/206Pb
ratio measurements within an analytical run
was 0.16 and 0.26% (2× RSD), respectively,
based on triplicate analyses of the children’s
blood samples at each single collection interval.
The average difference in 207Pb/206Pb and
208Pb/206Pb ratios between homogenized feces
duplicates was 0.11 and 0.16%, respectively
(n = 39 pairs). Precision and accuracy of lead
isotopic ratios of environmental samples were
estimated from repeated measurements of
NIST 981 (common lead isotopic standard
reference material). The long-term precision of
NIST 981 207Pb/206Pb and 208Pb/206Pb ratios
was 0.13 and 0.10% (2× RSD, n = 5 different
measurement days), and the accuracy was
within 0.05% of the certiﬁed ratio values.
Diaper blank was estimated to be approxi-
mately 5.8 ng lead per diaper, based on the
analyses of ultrapure water rinsed over the inner
surface of new diapers (n = 12). Fecal sample
contamination associated with homogenization
was < 5 ng lead, based on total procedural
homogenization blanks (n = 6) processed with
each batch of feces. These lead blank values are
three orders of magnitude less than the typical
amount of lead found in feces in a diaper, indi-
cating that fecal lead contamination associated
with collection and processing was negligible.
Results
Relationships between lead isotopic ratios of
environmental, feces, and blood samples. In
this study we were able to distinguish analyti-
cally the various household sources of envi-
ronmental lead, because the overall range of
207Pb/206Pb ratios of environmental samples
from all households (i.e., 4%) was approxi-
mately 20 times larger than the isotope ratio
measurement error (< 0.2%) (Figure 1). In
general, the lead isotopic compositions of
feces from the first round of sampling (i.e.,
before household intervention) match (cases 1
and 2, Figure 1A,B) or are bracketed (case 3,
Figure 1C) by the lead isotopic compositions
of the household dusts with lead loadings
exceeding U.S. EPA action levels that were
collected in the same visit.
The lead content of feces of case 3 in the
first visit indicates very variable daily lead
intake (Figure 1C). The highest daily fecal lead
content, 240 µg Pb, is up to 40 times higher
than the average daily fecal lead content of
approximately 6 µg Pb/day of the children in
the other two cases. We calculated a lead con-
tent–weighted grand average fecal isotopic
composition for each sampling round based on
the lead content and isotopic composition of
the daily fecal samples (Figure 2). These calcu-
lations indicate that the isotopic compositions
of blood and average feces of case 3 (Figure
2C) from the ﬁrst sampling round (t1) are in
much closer proximity to each other than what
is observed in the other two cases, consistent
with a greater relative impact of recent lead
exposures on blood lead levels.
In contrast to case 3, the lead intakes of
cases 1 and 2 in the first round of sampling
Children’s Health | Gwiazda et al.
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Table 1. Age (months) and blood lead levels (BPb; µg/dL) of children at enrollment, household lead abatement,
and subsequent sample collection visits.
Enrollment (t1) Abatement 2nd collection (t2) 3rd collection (t3)
Case Age BPb age Age BPb Age BPb
1 14 20.3 15.2 16.1 4.9 Withdrewa
2 46 29.3 47 49 25.4 53.4 25.2
3 20 18.3 22.1 27 12.9 36 16.6
aChild withdrew from the study before the third visit.(t1) were low, as reﬂected in the lead content
of feces (~ 6.5 and 5 µg/day, respectively)
(Figure 1A,B). However, the blood lead levels
in these two cases (20.3 and 29.3 µg/dL,
respectively) are comparable with or higher
than in case 3 (18.3 µg/dL). In addition, in
both cases 1 and 2, blood from all sampling
rounds contained higher 207Pb/206Pb ratios
than the average feces (Figure 2A,B).
Blood lead levels declined between the ﬁrst
(t1) and second (t2) visits in all three cases, even
though in cases 1 and 2 there was no signiﬁcant
change in the fecal lead content (Figure 2A,B).
In these two cases the blood isotopic composi-
tion at the second visit (t2) moved toward the
isotopic composition of feces (case 1) or
remained unchanged (t2, case 2).
In contrast to this, in case 3 the fecal lead
content decreased postintervention (t2) and
the blood 207Pb/206Pb ratios shifted away from
the isotopic composition of feces (Figure 2C).
When the lead content of feces again increased
at the ﬁnal round of sampling (case 3, t3), the
blood lead level also increased (from 12.9 to
16.6 µg/dL at t2 and t3, respectively), and its
isotopic composition shifted back closer to the
fecal lead 207Pb/206Pb ratio (Figure 2C). No
significant change was observed in case 2
between t2 and t3.
Estimates of bone lead contribution to
blood. Estimates of the amount of lead in
blood from bone at each collection time point
are obtained by applying Equations 1–6 to
blood and fecal lead concentrations and iso-
topic ratios of any two sampling rounds (i.e.,
t1 and t2, t1 and t3, t2 and t3). Thus, in cases 2
and 3, where three sampling rounds took
place, it is possible to obtain two estimates of
the bone lead contribution to blood for each
collection time point. This is because each
sampling round is used in two different pairs
of time points in the calculations. For exam-
ple, two estimates of bone lead contribution
to blood were calculated for t2, one estimate
based on the t1 and t2 sample collection pair,
and the other based on the t2 and t3 sample
collection pair (Table 2).
The estimated bone lead contribution to
blood in the oldest child (46 months of age,
case 2) is consistent throughout the three sam-
pling rounds and amounts to > 90% of blood
lead. In other words, uptake of lead from exter-
nal sources in that child supported < 10% of
the lead in blood throughout the 7.4 months
encompassed by the sampling rounds. Because
blood lead levels in that child ranged between
approximately 25 and 29 µg/dL throughout the
study, these results indicate that the chronically
elevated blood lead levels may be attributed to
the mobilization of substantial bone lead stores.
In case 1, where only two sampling visits took
place, the estimated bone lead contribution
averaged approximately 65% but decreased
slightly from the ﬁrst visit (73%) to the second
visit (58%), consistent with the reduction in
blood lead levels (from 20.3 to 14.9 µg/dL) and
with the absence of a reduction in fecal lead
elimination (i.e., lead intake) over the time
interval (Tables 1 and 2, Figure 2A).
In case 3, the amount of lead in blood
from bone is more variable. For this case, the
estimates of the bone lead contribution to
blood on the basis of the two different sam-
pling pairs are 36% at t1 (average of 19 and
53% calculated using the t1–t2 and t1–t3 col-
lection times, respectively), 65% at t2 (average
of 59 and 70% from pairs t1–t2 and t2–t3,
respectively), and 40% at t3 (average of 33 and
48% from pairs t1–t3 and t2–t3, respectively).
This variability in the estimates of bone lead
contribution calculated using two different
sampling pairs is produced by the relative size
of the analytical measurement error compared
with the isotopic differences between blood
and feces from two collection time points.
When isotopic differences between samples
collected at different times are small, the meas-
urement uncertainty in the isotopic values
results in large uncertainties in the estimates of
all parameters calculated from Equations 1–6.
The biokinetic factor K (Equations 5 and
6) relates the amount of lead in blood from
external intake with the lead content of feces,
that is, with the amount of lead ingested but
not absorbed. If it is assumed that GI absorp-
tion of lead in infants and small children is
on the order of 50% (Alexander et al. 1974;
Ziegler et al. 1978), the value of K should be
numerically equivalent to the more commonly
used BKSF defined as the increase in blood
lead per unit of lead absorbed across the GI
tract (Bowers and Cohen 1998; Bowers et al.
1994; U.S. EPA 2003). Data from infants fed
formula mixed with leaded water (Sherlock
and Quinn 1986) suggest a BKSF for small
children of 0.21–0.11 in the blood range of
13–30 µg/dL, if GI lead absorption is assumed
to be 0.5. Calculated biokinetic factors (K)
(Table 2) range from 0.83 to 0.12, although
they are generally much more consistent for a
given child. Comparison of biokinetic factors
(K) across children, and even across studies,
should be done with caution because this term
is not normalized to body weight.
Discussion
The three case studies presented here serve to
illustrate the application of this noninvasive iso-
topic approach to estimate the bone lead contri-
bution to blood in lead-poisoned children.
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Figure 1. Lead isotopic ratios of blood, feces, and environmental samples,
and household dust lead loadings from the first visit (t1). The vertical bar
below each dust isotopic composition symbol is the lead loading of that
particular dust sample according to the right ordinate scale. Numbers adja-
cent to the feces symbols indicate the day of the 4–5 day sequential feces
sample collection. (A) Case 1. Fecal lead content (µg): day 1, 7.0; day 2, 6.6;
day 3, 2.9; day 4, 9.0. (B) Case 2. Fecal lead content (µg): day 1, 5.1; day 2, 6.0;
day 3, 4.7; day 4, 1.9; day 5, 7.0. (C) Case 3. Fecal lead content (µg): day 1, 4.7;
day 2, 41; day 3, 240; day 4, 7.3.
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children reductions in blood lead levels post-
intervention may be buffered by the release of
significant amounts of lead from bone into
blood and thus may not adequately reflect
reductions in lead exposure from environmen-
tal sources. The endogenous source of this lead
mobilized into blood is presumed to be the
skeleton, because the skeleton contains most of
the body lead burden. Thus, the ability of a
household lead abatement intervention to pro-
duce considerable reductions in the blood lead
level of a chronically lead exposed child may be
substantially limited by the large contribution
of bone lead to blood.
This is best demonstrated by case 2, the
oldest child examined here (46 months of
age at enrollment), whose fraction of lead in
blood from bone was calculated to be > 90%
throughout the study. Supporting this, the
lead intake of this child was comparatively low
(~ 6 µg/day fecal lead elimination) and con-
stant throughout the three sampling visits, yet
the blood lead level was very elevated and
decreased only slightly over time (from 29.3
down to 25.2 µg/dL over 7 months). Thus,
even if the lead intake had been completely
eliminated by the household abatement inter-
vention, the expected decrease in blood lead
level would have been very small. This case, in
particular, illustrates the limitations of assum-
ing that blood lead levels are direct indicators
of current environmental lead exposure and
that lead hazard control measures would nec-
essarily be efﬁcacious in signiﬁcantly reducing
blood lead levels.
In cases 1 and 3, the estimated bone lead
contribution to blood was calculated to be
smaller than in case 2 (i.e., ~ 40–65% vs.
> 90%) and, at least in case 3, more variable
over time. The different estimated contribu-
tions of bone lead to blood lead over time in
the three children studied here could be due to
a number of factors, including differences in
exposure history and levels of lead accumulated
in bone. The child with the largest bone lead
contribution to blood (case 2, > 90%) was the
oldest of the three children and had a very low
lead intake, based on fecal lead elimination. In
this case, a larger store of bone lead accumu-
lated over a prolonged period (i.e., years) of
exposure to elevated environmental lead levels
could have maintained elevated blood lead lev-
els that only very slowly decreased over time
once the exposures were controlled. Under this
scenario, reduction of the elevated environ-
mental exposures to the case 2 child may have
occurred before the conduct of this study, con-
sistent with his relatively low fecal lead content
at enrollment. In the other two cases of
younger children (~ 1.5 years old), the bone
lead contribution to blood was smaller and
more variable (at least in case 3), suggesting a
smaller reservoir of lead in bone, possibly due
to a shorter history of environmental exposure.
Historically, the efﬁcacy of lead abatement
practices for reducing childhood lead exposures
has been evaluated based on reductions in
blood lead levels as indicators of lead exposure/
uptake (Aschengrau et al. 1994, 1998; CDC
1991; Charney et al. 1983; Farfel and Chisolm
1990; Hilts et al. 1995; Kimbrough et al.
1994). This approach does not sufficiently
consider the very important contribution of
accumulated bone lead stores in “buffering”
reductions in blood lead levels postinterven-
tion. Although it may be more difficult to
verify, a more accurate appraisal of the effec-
tiveness of lead hazard control measures would
be based on their success in reducing lead
intake.
Fecal lead content measured over several
days is one possible approach to estimating
the overall magnitude of childhood lead
intake. Fecal lead content should give an inte-
grated measure of lead exposure/intake from
all sources, dietary and environmental, inside
and outside the home. In contrast, other
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Figure 2. Lead content and isotopic composition of blood (circles) and feces (squares) from cases 1, 2, and 3
(A, B, and C, respectively). The visit number (1, 2, or 3) is shown on the symbols. The fecal lead isotopic com-
position shown is the lead content–weighted average of the lead isotopic compositions of the daily feces
collected in the visit. The white rectangles on the x-axes are the ranges in calculated isotopic composition of
lead in the skeleton.
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Table 2. Calculated fraction of lead in blood from bone, 207Pb/206Pb of bone, and biokinetic factor [in
(µg/dL)/(µg/day)], from Equations 1–6.
Sampling round
Case t1 t2 t3
1
Fraction of lead in blood from bone (%) 73 58 NA
Bone lead isotopic composition 0.8610 0.8610
Biokinetic factor K (Equation 5) 0.83 0.83
2a
Fraction of lead in blood from bone (%) 91–92 91–96 92–96
Bone lead isotopic composition 0.8737–0.8750 0.8742–0.8750 0.8737–0.8742
Biokinetic factor K (Equation 5) 0.48–0.14 0.21–0.48 0.14–0.21
3a
Fraction of lead in blood from bone (%) 19–53 59–70 33–48
Bone lead isotopic composition 0.8474–0.8517 0.8505–0.8517 0.8474–0.8505
Biokinetic factor K (Equation 5) 0.12–0.21 0.15–0.21 0.12–0.15
NA, not applicable.
aIn cases 2 and 3, two values can be calculated for each time point by pairing data from each sample collection time with
data from either one of the other two collection times (see “Materials and Methods”). For example, for t1 Equations 1–6
can be applied in combination with t2 or in combination with t3.approaches such as duplicate diet sampling
may not sufﬁciently reﬂect total lead exposure/
intake because duplicate diets do not reflect
potentially important environmental sources
of lead to children living in older housing or
in the proximity of soils with high lead con-
tent. Similarly, hand wipes may provide an
estimate of nondietary environmental lead
exposure in some cases (Duggan et al. 1985),
although they do not reliably reﬂect ingestion
of environmental lead.
There are, however, limitations with the
use of fecal lead content as a measure of lead
intake. First, collection of complete fecal sam-
ples over multiple days may not be feasible in
some cases. Second, variability among children
in GI lead absorption should ideally be taken
into consideration if fecal lead content were to
be used as a direct surrogate of lead uptake
and intake. Third, because excreted fecal lead
reﬂects unabsorbed ingested lead in addition
to lead eliminated via endogenous fecal (e.g.,
biliary) routes, variation in these physiologic
processes from child to child may introduce
variation not attributable to environmental
lead exposure. Nonetheless, fecal lead content
still may be the among the most accurate indi-
cators of the amount and isotopic composition
of lead the child is ingesting, and as a result, it
may serve as a useful quantitative index of the
extent of oral lead exposure from all sources
(diet and environment).
Assumptions and limitations of this
isotopic approach. The mathematical approach
used here to calculate the bone lead contribu-
tion to blood relies on a number of assump-
tions, including a) that the lead isotopic
composition of feces reﬂects the lead isotopic
composition of ingested lead that is incorpo-
rated into the circulation, and b) that the iso-
topic composition of the skeleton remains
constant throughout the 3- to 6-month inter-
val between consecutive sampling visits.
Although prior studies have not systematically
validated the ﬁrst assumption, it is supported
by a number of published observations. Studies
where lead intake and excretion were measured
in animals and humans showed that an
increase in lead intake is quickly followed by
an increase in fecal lead excretion (Barltrop and
Killala 1967; Kehoe 1987; Ziegler et al. 1978).
In addition, fecal lead excretions by children
suffering elevated lead exposures have been
shown to correlate with the degree of lead
paint hazards in their household environment
(Hammond et al. 1980). Perhaps most rele-
vant to the present study, Rabinowitz (1987)
showed that the lead isotopic compositions of
leaded paints in the household environments
of lead-poisoned children matched the isotopic
compositions of the children’s bloods and their
excreted feces. These latter observations are
replicated in the three cases reported here
where the lead isotopic compositions of feces
matched or were within the range of the lead
isotopic compositions of the household dusts
with the highest lead loadings.
An additional factor related to the first
assumption that is not included in the model
but that may affect the utility of fecal lead con-
tent as a surrogate of lead intake is the elimina-
tion of lead into feces via endogenous (e.g.,
biliary) pathways. Biliary lead excretion has
been shown to range between 40 and 85% of
total body lead excretion in nonhuman pri-
mates (Cremin et al. 2001; O’Flaherty et al.
1996) and < 46% in adult humans (Rabinowitz
et al. 1976), and it is estimated to be at least
50% in infants (Ziegler et al. 1978). Assuming
that the lead isotopic composition of bile
matches that of blood, the biliary elimination
of endogenous lead into feces would shift the
lead isotopic value of feces toward the isotopic
value of blood, although the extent of this shift
would depend on the amount (e.g., micro-
grams) of lead eliminated from this biliary
route compared with the amount of lead in the
feces (i.e., unabsorbed lead from oral intake).
Consequently, the measured difference in lead
isotopic composition between feces and blood
would be smaller than the true isotopic differ-
ence between blood and the oral intake. Here,
we conservatively chose to not include in the
model a term for endogenous biliary lead
excretion into feces because endogenous fecal
lead excretion is unknowable for a particular
child, and including this term in the model
would introduce a large uncertainty in the cal-
culation of the bone lead contribution to
blood. Functionally, the impact of not includ-
ing this variable in the model produces calcu-
lated bone lead contributions to blood that, if
anything, are minimum values that could be
larger for a particular child.
The second assumption of this model is
that the isotopic composition of the skeleton
remains constant throughout the sampling vis-
its [i.e., the model assumes (207Pb/206Pb)bone
t1 =
(207Pb/206Pb)bone
t2]. It is possible, however,
that changes in the blood isotopic composi-
tion because of reductions in lead intake after
intervention, for example, could produce
small changes in the isotopic composition of
metabolically active regions of bone that
exchange lead with blood. Accordingly, the
bone lead isotopic composition could change
slightly toward that of blood, rather than
remain constant throughout the study. If
allowance is made in the model for a change
in bone isotopic composition toward that of
blood, as the magnitude of external sources of
exposure changes, the estimated contribution
of lead from bone to blood actually increases.
Thus, the approach used here, which assumes
that the bone lead isotopic composition does
not change with time, yields a minimum cal-
culated value for the contribution of bone lead
to blood.
Conclusions
We present a noninvasive isotopic approach to
estimate the bone lead contribution to blood in
children following interventions to reduce
environmental lead exposures. Illustration of
this method using three cases of lead-poisoned
children provides evidence that mobilized
skeletal lead stores may contribute a signiﬁcant
fraction of lead to blood, up to 90% or more
in one case presented here, which may substan-
tially “buffer” reductions in blood lead levels
after environmental lead remediation. Because
the accumulated skeletal lead burden likely
varies from child to child, depending partly on
the child’s age and lead exposure history, it
should be expected that blood lead levels
would decrease at different rates postinterven-
tion, depending on the contributions of bone
lead to blood in different children. This sug-
gests that the efﬁcacy of lead hazard remedia-
tion efforts should be evaluated over prolonged
periods (i.e., ≥ 6–12 months) to allow ade-
quate time for depletion of accumulated skele-
tal lead stores and a reduction in their absolute
contribution to blood lead levels. Observations
from this study also support the use of fecal
lead content and isotopic composition as a
proxy for the identiﬁcation of sources of lead
exposure.
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